How are fast food restaurants responding to GLP-1 medications?

Fast food restaurants are adapting by emphasizing smaller portions, protein-forward options, and nutrient-dense offerings to cater to consumers using GLP-1 medications.

Which fast food chains have introduced new menus for GLP-1 users?

Chipotle has introduced protein cups, Smoothie King launched a 'GLP-1 Support menu' in October 2024, and Shake Shack released its 'Good Fit Menu' in December 2025.

How do GLP-1 users' dining habits differ from others?

While GLP-1 users still dine out frequently, their ordering habits have changed, leading them to seek smaller portions and healthier, protein-rich choices.

Home / Business and Economy / GLP-1 Drugs Reshape Fast Food Industry

GLP-1 Drugs Reshape Fast Food Industry

7 Feb

•

Summary

Fast food chains are adapting to GLP-1 users' changing eating habits.
Many chains now emphasize smaller portions and protein-rich options.
Consumer spending on fast food and groceries has decreased by 5%.

The American fast food industry, valued at nearly $418 billion, is strategically adapting to the widespread use of GLP-1 weight loss medications. Despite the medications' impact on appetite, data indicates that 97% of GLP-1 users continue to dine out monthly, albeit with altered ordering habits. Fast-casual and fast-food brands are responding by highlighting smaller portions, protein-dense meals, and nutrient-rich offerings, reflecting a cultural shift towards more health-conscious consumption.

Chains like Chipotle have introduced protein cups, while Smoothie King launched a dedicated "GLP-1 Support menu" in October 2024. Shake Shack followed with its "Good Fit Menu" in December 2025, featuring items with detailed nutritional information. Even without new menus, companies are expected to pivot their marketing to target GLP-1 users, emphasizing how their offerings can fit into a weight-loss plan. This adaptation is driven by a desire to retain market share as overall calorie consumption decreases.